Biotech Stocks

Biotech Stocks
Source: ©iStock.com/AlexRaths
Biotechnology has been one of the fastest advancing industries in the past decade. With new medicine always being synthesized and new ways to fertilize crops, the sector is diverse and prosperous, especially as corporations look for new findings or better efficiency. Subsequently, the biotech stocks are booming and should continue to rise in the future.
Some of the best biotech stocks to buy in 2014 include Amgen (NYSE:AMGN) and Gilead Sciences (NYSE:GILD) although many smaller biotech corporations are on the rise and worth a consideration. Biotech stocks can cure your ailing portfolio and lead you down the road to recovery.

Biotechnology Sector Quote (CIX: MSECTOR5151)

Recent Articles

3 Tips To Find Winning Biotech Stocks

Finding biotech stocks to invest in involves some level of danger. Use these tips to help determine your best bets, and start with these 3 biotechs to buy More 

iShares Nasdaq Biotechnology Index (ETF) (IBB): Nibble on the Long Side

Biotech stocks, after some prolonged weakness, are starting to show promising relative and absolute strength. That means opportunity in the IBB. More 

Trade of the Day: Nautilus, Inc. (NYSE:NLS)

Nautilus (NLS) shares fell 3.7% Monday on no news, offering traders a phenomenal entry point. More 

Opko Health Inc.: FDA Denial Won’t Kill OPK

The approval delay of Rayaldee, Opko Health's new billion-dollar drug, won't hurt its market performance. OPK is a high-risk/high-reward stock. More 

Gilead Sciences, Inc.: GILD Could Squeeze the Bears From Here

Gilead Sciences enjoyed a rally Monday along with the rest of the biotech sector. This breakout could be followed up by a short squeeze in GILD stock. More 

This Big Biotech ETF Faces a Key Technical Test

Those who follow our blog know we are proponents of technical analysis in reading the trends of the market. A trend in this biotech ETF suggests opportunity More 

3 Biotech Stocks That Are Ripe for a Fall

Biotech stocks are looking particularly weak right now, and these three companies in specific still have more downside to explore. More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is a Buy, But Not for Long

The iShares Nasdaq Biotechnology ETF (IBB) has yet to pull off something that other parts of the market have -- and that spells opportunity in IBB. More 

4 Healthcare Stocks on Shaky Ground – MRK LLY AZN BMY

Biotechnology stocks have broken down, and certain pharmaceutical stocks are now following suit. Could Merck and other pharmas suffer more downside? More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Ready to Bounce!

The IBB ETF of biotech stocks has reached support levels that could spark a better bounce. Active investors should take notice. More